Stay updated with breaking news from Landmark Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day 08.09.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Moderna Reviews Clinical Trial Programs Across Port...
Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefitInterim data from
/CNW/ - More than a million Canadians are forecast to be living with dementia by 2030, a date by which it is estimated that approximately 21 people will be...
/CNW/ - September 6, 2022 – Canada faces serious challenges in supporting people living with dementia and their care partners over the next three decades....
The blood pressure–lowering effects of dietary salt substitutes have a clear protective effect on hard clinical outcomes, leading to a reduction in heart attack, stroke, and death, a meta-analysis shows.